Tech giant Apple faces a $634 million legal blow after a U.S. jury ruled its Apple Watch infringed medical tech company Masimo's blood-oxygen monitoring patents. The Friday verdict adds fuel to a years-long corporate clash that’s reshaping wearable tech innovation. ⌚️
Why It Matters
The lawsuit claims Apple’s Watch Series 9 and Ultra 2 models used Masimo’s pulse oximetry tech without permission. This isn’t just about $$$ – it’s a high-stakes fight over who controls health-monitoring breakthroughs millions rely on.
What’s Next?
Apple says it’ll appeal, while Masimo calls this "a significant win" for innovation protection. Meanwhile, U.S. authorities are reviewing whether updated Apple Watches should face import bans – a saga that began with 2023 restrictions.
Bigger Picture
This case highlights growing tensions between tech and healthcare industries. As smartwatches evolve into medical devices, patent wars could determine which companies lead the $100B+ wearable market. 💡
